Vedanta Biosciences, Inc. Vedanta Biosciences, Inc.

  • Home
  • About
    • Overview
    • Team
    • Scientific Co-Founders and Advisors
    • Board of Directors
    • Investors
  • Pipeline
    • Overview
    • VE303
    • VE202
    • VE800
    • VE707
    • VE416
    • Partnerships
    • Intellectual Property
  • Clinical Trials
    • VE303
    • VE202
    • VE800
    • VE416
    • Expanded Access
  • Platform
    • How Our Drugs Work
    • Discovery Platform
    • Manufacturing Platform
    • Publications
  • News & Media
    • Overview
    • Press Releases
    • In The News
  • Careers
  • Contact
News & Media

News & Media

  • Overview
  • Press Releases
  • In The News

Press Releases

May 7, 2019

Vedanta Biosciences Key Microbiome Patent Upheld in European Opposition Proceedings

Jan 23, 2019

Vedanta Biosciences Publishes Seminal Research in Leading Scientific Journal for its Immuno-oncology Candidate, VE800

Dec 24, 2018

Vedanta Biosciences Raises $27 Million Series C Financing to Advance Clinical Pipeline of Microbiome-Derived Product Candidates

Dec 17, 2018

Vedanta Biosciences Initiates Phase 2 Study for Lead Rationally-Defined Bacterial Consortium Product Candidate, VE303

Dec 10, 2018

Bristol-Myers Squibb and Vedanta Biosciences Announce a New Clinical Collaboration to Evaluate OPDIVO® (nivolumab) and VE800 in Patients with Advanced or Metastatic Cancers

Nov 27, 2018

Vedanta Biosciences Announces Initiation of Phase 1 Clinical Study with Janssen of Microbiome-Derived Product Candidate for Inflammatory Bowel Disease

Nov 16, 2018

Pioneer of the Year award - Silvia Caballero!

Nov 6, 2018

Vedanta Biosciences Announces Preclinical Data on Microbiome-Derived Immuno-Oncology Candidate

Oct 4, 2018

Vedanta Biosciences Announces Successful Phase 1a/1b Data Demonstrating Safety, Tolerability, and Proof of Mechanism for Lead, Rationally Defined Bacterial Consortium Product Candidate, VE303

Sep 5, 2018

Vedanta Biosciences Appoints Susan Dillon, PhD, to Board of Directors

  • « Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • Next »
RSS Feed
© 2023 Vedanta Biosciences, Inc. All Rights Reserved.
Privacy Policy Disclaimer Sitemap